tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kalpit Patel, 76 are a BUY (72.38%), 29 are a HOLD (27.62%).
Analyst Kalpit Patel, currently employed at B. RILEY, carries an average stock price target met ratio of 47.84% that have a potential upside of 50.71% achieved within 172 days.
Kalpit Patel’s has documented 207 price targets and ratings displayed on 22 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on KYMR, Kymera Therapeutics at 22-Dec-2025.
Analyst best performing recommendations are on XFOR (X4 PHARMACEUTICALS).
The best stock recommendation documented was for KYMR (KYMERA THERAPEUTICS) at 11/2/2023. The price target of $16 was fulfilled within 5 days with a profit of $3.92 (32.45%) receiving and performance score of 64.9.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 24-Nov-2025
$10
$4.27 (74.52%)
$25
3 months 5 days ago
(24-Nov-2025)
0/5 (0%)
$3.26 (48.37%)
Buy Since 20-Apr-2021
$12
$6.27 (109.42%)
$10
3 months 29 days ago
(31-Oct-2025)
1/14 (7.14%)
$3.93 (48.70%)
174
$13
$7.27 (126.88%)
$17
6 months 17 days ago
(12-Aug-2025)
0/9 (0%)
$5.78 (80.06%)
Buy Since 11-Jun-2020
$48
6 months 18 days ago
(11-Aug-2025)
3/9 (33.33%)
$24.6 (105.13%)
192
Hold Since 07-Aug-2024
$14
$8.27 (144.33%)
$17
9 months 27 days ago
(02-May-2025)
1/9 (11.11%)
$4.7 (50.54%)
12
Which stock is Kalpit Patel is most bullish on?
Which stock is Kalpit Patel is most reserved on?
What Year was the first public recommendation made by Kalpit Patel?
